Cargando…

Kreuth V initiative: European consensus proposals for treatment of hemophilia using standard products, extended half-life coagulation factor concentrates and non-replacement therapies

This report contains the updated consensus recommendations for optimal hemophilia care produced in 2019 by three Working Groups (WG) on behalf of the European Directorate for Quality of Medicines and Healthcare in the frame of the Kreuth V Initiative. WG1 recommended access to prophylaxis for all pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peyvandi, Flora, Berger, Karin, Seitz, Rainer, Hilger, Anneliese, Hecquet, Marie-Laure, Wierer, Michael, Buchheit, Karl-Heinz, O’Mahony, Brian, Bok, Amanda, Makris, Mike, Mansmann, Ulrich, Schramm, Wolfgang, Mannucci, Pier Mannuccio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ferrata Storti Foundation 2020
Materias:	Guideline Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395279/ https://www.ncbi.nlm.nih.gov/pubmed/32467138 http://dx.doi.org/10.3324/haematol.2019.242735

Ejemplares similares

Hemophilia therapy: the future has begun
por: Mannucci, Pier Mannuccio
Publicado: (2020)

Aging with Hemophilia: The Challenge of Appropriate Drug Prescription
por: Mannucci, Pier Mannuccio
Publicado: (2019)

Recombinant FVIII: the milestone of modern hemophilia treatment
por: Mannucci, Pier Mannuccio
Publicado: (2023)

A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH
por: van Galen, Karin P. M., et al.
Publicado: (2021)

The management of hemophilia in elderly patients
por: Franchini, Massimo, et al.
Publicado: (2007)

Past, present and future of hemophilia: a narrative review
por: Franchini, Massimo, et al.
Publicado: (2012)

Genome-Wide Association Studies in Myocardial Infarction and Coronary Artery Disease
por: Mannucci, Pier Mannuccio, et al.
Publicado: (2010)

Fc-fusion technology and recombinant FVIII and FIX in the management of the hemophilias
por: Mancuso, Maria Elisa, et al.
Publicado: (2014)

How we manage cardiovascular disease in patients with hemophilia
por: Franchini, Massimo, et al.
Publicado: (2023)

Evolution of Haemophilia Care in Europe: 10 years of the principles of care
por: Noone, D., et al.
Publicado: (2020)

Extended Half-Life Coagulation Factors: A New Era in the Management of Hemophilia Patients
por: Ar, Muhlis Cem, et al.
Publicado: (2019)

International recommendations on the diagnosis and treatment of acquired hemophilia A
por: Tiede, Andreas, et al.
Publicado: (2020)

Joint Dysfunction as a Cause of Spontaneous Subclinical Bleeding in Infants with Hemophilia
por: Boccalandro, Elena Anna, et al.
Publicado: (2023)

The German Hemophilia Registry: Growing with Its Tasks
por: Duda, Heike, et al.
Publicado: (2020)

Clinical risk scores for the early prediction of severe outocomes in patients hospitalized for COVID-19: comment
por: Rossio, Raffaella, et al.
Publicado: (2021)

Core data set on safety, efficacy, and durability of hemophilia gene therapy for a global registry: Communication from the SSC of the ISTH
por: Konkle, Barbara, et al.
Publicado: (2020)

Product type and other environmental risk factors for inhibitor development in severe hemophilia A
por: Peyvandi, Flora, et al.
Publicado: (2018)

The Arrival of Gene Therapy for Patients with Hemophilia A
por: Castaman, Giancarlo, et al.
Publicado: (2022)

Annual Bleeding Rates: Pitfalls of Clinical Trial Outcomes in Hemophilia Patients
por: Keipert, Christine, et al.
Publicado: (2020)

Antithrombotic Treatment in Patients With Hemophilia: an EHA-ISTH-EAHAD-ESO Clinical Practice Guidance
por: Schutgens, Roger E.G., et al.
Publicado: (2023)

I16 Hemophilia
por: Mannucci, P.M.
Publicado: (2007)

Coagulation Factor IX for Hemophilia B Therapy 
por: Orlova, N. A., et al.
Publicado: (2012)

Markedly Reduced FVIII Recovery Associated with Anti-FVIII Peg Antibodies after BNT162b2 Sars-Cov-2 Vaccination
por: Valsecchi, Carla, et al.
Publicado: (2022)

Reduced FVIII recovery associated with anti-FVIII PEG antibodies after BNT162b2 SARS-CoV-2 vaccination
por: Valsecchi, Carla, et al.
Publicado: (2022)

Issues in assessing products for the treatment of hemophilia – the intersection between efficacy, economics, and ethics
por: Farrugia, Albert, et al.
Publicado: (2015)

Updates on Novel Non-Replacement Drugs for Hemophilia
por: Gualtierotti, Roberta, et al.
Publicado: (2022)

Mild and Moderate Hemophilia A: Neglected Conditions, Still with Unmet Needs
por: Castaman, Giancarlo, et al.
Publicado: (2023)

Utilization Patterns of Coagulation Factor Consumption for Patients with Hemophilia
por: Lee, Soo Ok, et al.
Publicado: (2016)

Protein-Engineered Coagulation Factors for Hemophilia Gene Therapy
por: Samelson-Jones, Benjamin J., et al.
Publicado: (2018)

Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19
por: Song, Jing-Chun, et al.
Publicado: (2020)

Real-World Analysis of Dispensed IUs of Coagulation Factor IX and Resultant Expenditures in Hemophilia B Patients Receiving Standard Half-Life Versus Extended Half-Life Products and Those Switching from Standard Half-Life to Extended Half-Life Products
por: Tortella, Bartholomew J., et al.
Publicado: (2018)

Prevalence of selected bleeding and thrombotic events in persons with hemophilia versus the general population: A scoping review
por: Shapiro, Amy D., et al.
Publicado: (2022)

Thrombotic thrombocytopenic purpura and other immune-mediated blood disorders following vaccination against SARS-CoV-2
por: Mannucci, Pier Mannuccio
Publicado: (2021)

Plasma Clearance of Coagulation Factor VIII and Extension of Its Half-Life for the Therapy of Hemophilia A: A Critical Review of the Current State of Research and Practice
por: Sarafanov, Andrey G.
Publicado: (2023)

Understanding the Impact of Aberrant Splicing in Coagulation Factor V Deficiency
por: Paraboschi, Elvezia Maria, et al.
Publicado: (2019)

Recommendation for Resuming Elective Surgery during the Normalising Period in COVID-19 Pandemic
por: Sungur, Zerrin, et al.
Publicado: (2021)

Handwriting Analysis in Children and Adolescents with Hemophilia: A Pilot Study
por: Pasta, Gianluigi, et al.
Publicado: (2020)

STUDIES ON BLOOD COAGULATION : IV. THE NATURE OF THE CLOTTING DEFICIENCY IN HEMOPHILIA
por: Eagle, Harry
Publicado: (1935)

Management and treatment of children, young people and adults with systemic lupus erythematosus: British Society for Rheumatology guideline scope
por: Md Yusof, Md Yuzaiful, et al.
Publicado: (2023)

Position statement for the diagnosis and management of anogenital warts
por: O'Mahony, C., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_21hhjlrsr9ujh3jog7535j58fe